You-Cheol Hwang

25PUBLICATIONS
48CO-AUTHORS
Pharmaceutical delivery technologiesPharmacogenomicsSocial epidemiologyMetabolic medicineComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Mar 26, 2026
Efficacy and Safety of Fixed-Dose Combinations of Sitagliptin and Empagliflozin as Add-On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double-Blind, Multi-Centre, Placebo-Controlled, Phase III Trial.

Soo Lim, Tae Nyun Kim, Ji Oh Mok

|Aug 14, 2025
Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trial.

Yun Kyung Cho, Jae-Hyoung Cho, Sang-Mo Hong

|Jul 29, 2025
Comparative efficacy and safety of Evogliptin in type 2 diabetes patients above and below 65 years.

Jimi Kim, Young-Seol Kim, You-Cheol Hwang

|Nov 15, 2024
Identification of Metabolic Patterns in Korean Patients With Type 2 Diabetes and Their Association With Diabetes-Related Complications.

Minji Kang, Kumhee Son, You-Cheol Hwang

|Oct 03, 2024
Machine Learning-Based Prediction of Neurodegenerative Disease in Patients With Type 2 Diabetes by Derivation and Validation in 2 Independent Korean Cohorts: Model Development and Validation Study.

Hyunji Sang, Hojae Lee, Jaeyu Park

|Jul 09, 2024
Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study.

Kyung Ah Han, You-Cheol Hwang, Shin Je Moon

Pageof 5

Frequent Collaborators

4 joint publications

In-Kyung Jeong

4 joint publications

Ji Eun Jun

2 joint publications

Cheol-Young Park

2 joint publications

Kyu Jeung Ahn